$ATRA News Article - CHMP Recommends Approval of Atara Biotherapeutics' Ebvallo(TM) (tabelecleucel) for the Treatment of Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease
https://marketwirenews.com/news-releases/chmp...45333.html